Olfr39 Activators
Chemical activators of Or7d9 function primarily through modulation of intracellular signaling pathways, particularly those involving protein kinases and calcium signaling. Forskolin, for example, raises intracellular cAMP levels, leading to PKA activation. PKA, a key regulatory kinase, can phosphorylate various substrates, potentially including proteins related to Or7d9 activation. Similarly, PMA and Ionomycin manipulate PKC activity and calcium levels respectively, creating a cascade of events that can influence the activation state of multiple proteins, including Or7d9. Other chemicals like 8-Bromo-cAMP, Okadaic Acid, and Thapsigargin also manipulate these signaling cascades. 8-Bromo-cAMP, a cAMP analog, directly stimulates PKA activity, while Okadaic Acid disrupts protein dephosphorylation pathways, leading to an altered phosphorylation landscape. Thapsigargin, by disrupting calcium storage, induces a rise in cytosolic calcium, activating calcium-dependent proteins that could intersect with Or7d9's regulatory network.
The remaining chemicals, including Chelerythrine Chloride, A23187, Staurosporine, Bisindolylmaleimide I, Calphostin C, and H-89 Dihydrochloride, each contribute to the modulation of kinase activities or calcium signaling in unique ways. These alterations in the cellular signaling milieu can indirectly lead to the activation of Or7d9. The precise mechanisms by which these chemicals contribute to Or7d9 activation may involve a complex interplay of phosphorylation events, changes in intracellular ion concentrations, and the modulation of downstream effector proteins. The cumulative effect of these biochemical interactions is the functional activation of Or7d9, achieved through a network of signaling pathways and molecular interactions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in numerous signaling pathways. PKC activation can lead to downstream effects on various proteins, potentially including the activation of Or7d9. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calmodulin and other calcium-binding proteins. This calcium signaling can influence multiple cellular processes, possibly leading to the activation of Or7d9. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cAMP analog that activates PKA, mimicking the effect of increased cAMP levels. This activation can influence various proteins, potentially leading to the activation of Or7d9. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation of cellular proteins. This inhibition can indirectly influence the activation status of various proteins, possibly including Or7d9. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels. This can activate several calcium-dependent proteins, potentially influencing Or7d9 activation. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine chloride is a PKC inhibitor that, paradoxically, can lead to altered regulation and activation of different protein kinases and their substrates, possibly affecting Or7d9 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as an ionophore, facilitating the transport of Ca2+ across cellular membranes. This alteration in calcium signaling can activate various proteins and pathways, potentially influencing Or7d9 activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, can lead to complex changes in phosphorylation patterns within cells, indirectly affecting various signaling pathways and potentially leading to Or7d9 activation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective inhibitor of PKC, which can alter the phosphorylation status of various proteins and potentially affect the activation of Or7d9. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C, a PKC inhibitor, can lead to changes in kinase activity and protein phosphorylation states, potentially resulting in the activation of Or7d9. | ||||||